Skip to the page

Data / Form D filings / BioCement Technologies, Inc.

BioCement Technologies, Inc.: Form D filing

BioCement Technologies, Inc., a company in Seattle, WA, filed a Form D with the SEC in 2016. The latest, on April 8, 2016, reports $251,833 sold of a $400,000 offering to 7 investors.

Find out what BioCement Technologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1301 SECOND AVENUE, SUITE 2850, Seattle, WA, 98101
Phone
(206) 332-1210
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2013
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1670985

The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 8, 2016New notice$400,000$251,833$148,1677Mar 28, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David WeldDirector
Gaylord KelloggExecutive Officer, Director
Marshall PiattExecutive Officer
Nicholas LodatoExecutive Officer, Director
Travis WambekeDirector
Scott HeydonDirector

Other companies in Washington that filed recently

Every Form D from the week of Apr 4, 2016 · All recent filings in Washington · All recent Other filings

Read from SEC EDGAR. Amount sold is what BioCement Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.